Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core. (Q40626990)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Timothy Fouts

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Xuemin Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Lingmei Ding

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Anthony De Vico

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Jan zur Megede

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Susan Barnett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paul Spearman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

22 September 2017

314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

636-649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14554091%20AND%20SRC:MED&resulttype=core&format=json

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Identification of the fusion peptide of primate immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Jitters jeopardize AIDS vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

HIV interactions with CD4: a continuum of conformations and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Optimization of experimental variables influencing reporter gene expression in hepatoma cells following calcium phosphate transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Investigation of Human Immunodeficiency Virus Fusion Peptides. Analysis of Interrelations Between Their Structure and Function

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900467-7

7 January 2021